Promind
Promind, licence 80079141: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Ace Nootropics
- NPN or DIN-HM
- 80079141
- Status
- Active licence
- Licence date
- 21 July 2017
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Magnésium Source : Glycinate de magnésium | 25.0 milligramme | 25,000 µg |
| Rhodiola rosea Source : Rhodiola rosea - Racine Potency : 1.0 % Salidroside | Not specified | Not calculated |
| Niacinamide Source : Niacinamide | 75.0 milligramme | Not calculated |
| 5-Hydroxy-L-tryptophane Source : 5-HTP | 200.0 milligramme | Not calculated |
| Zinc Source : Citrate de zinc | 10.0 milligramme | 10,000 µg |
| Rhodiola rosea Source : Rhodiola rosea - Racine Potency : 3.0 % Rosavins | 200.0 milligramme | Not calculated |
Non-medicinal ingredients
Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1.0 Capsule | 1.0 Jour(s) |
Uses authorised in Canada
Help(s) support cognitive function and/or reduce mental fatigue (in cases of mental stress). Helps normal growth and development.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
People sensitive to nicotinic acid may experience flushing of the skin that is generally mild and transient. If you experience irritability or insomnia, discontinue use.
- Contre-indications
Do not use if you have scleroderma. If you have bipolar disorder or bipolar spectrum disorder, do not use this product.
- Précautions et mises en garde
Do not use if safety seal is broken or missing. Store in a cool dry place. KEEP OUT OF REACH OF CHILDREN. Consult a health care practitioner if sleeplessness persists continuously for more than 3 weeks (chronic insomnia). If symptoms persist or worsen, consult a health care practitioner. If you are taking hormone replacement therapy (HRT) or birth control pills, consult a health care practitioner prior to use. Consult a health care practitioner prior to use if you are taking carbidopa or drugs/supplements with serotonergic activity. These may include, but are not limited to, L-tryptophan, S-adenosylmethionine (SAMe), St. John's wort, antidepressants, pain killers, over the counter cough and cold medication containing dextromethorphan, anti-nausea medication and anti-migraine medication. Discontinue use and consult a health care practitioner if you show signs of weakness, oral ulcers, or abdominal pain accompanied by severe muscle pain or if you experience skin changes. If you are pregnant or breastfeeding, consult a health care practitioner prior to use. Some people may experience drowsiness. Exercise caution if operating heavy machinery, driving a motor vehicle or involved in activities requiring mental alertness. Some people may experience diarrhea, nausea, vomiting and abdominal pain.
Source
Official Health Canada record, licence 80079141
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.